A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.

PubWeight™: 8.37‹?› | Rank: Top 0.1%

🔗 View Article (PMID 24076059)

Published in Gastroenterology on September 25, 2013

Authors

Emma P Halmos1, Victoria A Power2, Susan J Shepherd2, Peter R Gibson3, Jane G Muir3

Author Affiliations

1: Department of Medicine, Eastern Health Clinical School, Monash University, Box Hill, Victoria, Australia; Department of Gastroenterology, Central Clinical School, Monash University, Melbourne, Victoria, Australia. Electronic address: Emma.Halmos@monash.edu.
2: Department of Medicine, Eastern Health Clinical School, Monash University, Box Hill, Victoria, Australia.
3: Department of Medicine, Eastern Health Clinical School, Monash University, Box Hill, Victoria, Australia; Department of Gastroenterology, Central Clinical School, Monash University, Melbourne, Victoria, Australia.

Associated clinical trials:

Effect of FODMAPs on Mucosal Inflammation in IBS Patients | NCT03221790

Evaluation of Bowel Sensitivity Threshold in IBS Patients Versus in Healthy Controls Using the Novel Rapid Barostat Bag | NCT03224494

Low FODMAPs Diet vs. Specific Dietary Advice in Patients With IBS Diarrheal Variant (DIETSINIBS) | NCT03423069

Effect of Physical Form of Apples on Gastrointestinal Function and Satiety: a MRI Study | NCT03714464

Articles citing this

(truncated to the top 100)

Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther (2015) 2.87

The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol (2014) 2.32

The gut microbiome in health and in disease. Curr Opin Gastroenterol (2015) 1.33

Brain-gut microbiome interactions and functional bowel disorders. Gastroenterology (2014) 1.22

Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol (2014) 1.19

Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome. Am J Gastroenterol (2015) 1.14

Irritable bowel syndrome. Nat Rev Dis Prim (2016) 1.14

Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena? Am J Gastroenterol (2015) 1.13

Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr (2015) 1.07

Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol (2014) 1.06

Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome. Am J Gastroenterol (2016) 1.04

Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World. J Neurogastroenterol Motil (2015) 1.04

Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver (2015) 1.03

Re: Halmos et al, A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology (2014) 0.97

Low FODMAP diet in the treatment of irritable bowel syndrome: is it the end of the road or the beginning of a journey? Gastroenterology (2014) 0.97

Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol (2014) 0.97

Fructose Malabsorption in Patients With Irritable Bowel Syndrome-like Symptoms: What Is the Role in the Pathogenesis and Clinical Implication? J Neurogastroenterol Motil (2014) 0.95

Underlying molecular and cellular mechanisms in childhood irritable bowel syndrome. Mol Cell Pediatr (2016) 0.94

The Low FODMAP Diet and Its Application in East and Southeast Asia. J Neurogastroenterol Motil (2015) 0.91

New and Emerging Treatment Options for Irritable Bowel Syndrome. Gastroenterol Hepatol (N Y) (2015) 0.91

Artificial Sweeteners: A Systematic Review and Primer for Gastroenterologists. J Neurogastroenterol Motil (2016) 0.91

The spectrum of noncoeliac gluten sensitivity. Nat Rev Gastroenterol Hepatol (2015) 0.89

Diagnosis and management of chronic constipation in adults. Nat Rev Gastroenterol Hepatol (2016) 0.88

New therapeutic option for irritable bowel syndrome: serum-derived bovine immunoglobulin. World J Gastroenterol (2015) 0.88

Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol (2016) 0.87

Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation. World J Gastroenterol (2015) 0.86

Novel perspectives on therapeutic modulation of the gut microbiota. Therap Adv Gastroenterol (2016) 0.86

Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. Int J Gen Med (2016) 0.86

Lactose Intolerance in Adults: Biological Mechanism and Dietary Management. Nutrients (2015) 0.86

Non-celiac gluten sensitivity - why worry? BMC Med (2014) 0.86

Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol (2016) 0.85

Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal Cancer. Front Pharmacol (2016) 0.84

Dietary fructose intolerance, fructan intolerance and FODMAPs. Curr Gastroenterol Rep (2014) 0.84

Increased chromogranin a cell density in the large intestine of patients with irritable bowel syndrome after receiving dietary guidance. Gastroenterol Res Pract (2015) 0.84

Management of gastrointestinal involvement in scleroderma. Curr Treatm Opt Rheumatol (2015) 0.84

Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2015) 0.84

Assessing of Celiac Disease and Nonceliac Gluten Sensitivity. Gastroenterol Res Pract (2015) 0.83

Treatment of abdominal pain in irritable bowel syndrome. J Gastroenterol (2014) 0.83

Irritable bowel syndrome and food interaction. World J Gastroenterol (2014) 0.82

A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D. Am J Gastroenterol (2016) 0.82

Diet in irritable bowel syndrome. Nutr J (2015) 0.81

Low-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: a randomized, multicenter, double-blind clinical trial. Nutr J (2015) 0.81

Dietary guidance normalizes large intestinal endocrine cell densities in patients with irritable bowel syndrome. Eur J Clin Nutr (2015) 0.81

Randomised clinical trial: low-FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syndrome. Aliment Pharmacol Ther (2016) 0.80

Feasibility and Usability Pilot Study of a Novel Irritable Bowel Syndrome Food and Gastrointestinal Symptom Journal Smartphone App. Clin Transl Gastroenterol (2016) 0.80

Bloating and functional gastro-intestinal disorders: where are we and where are we going? World J Gastroenterol (2014) 0.80

Consistent Prebiotic Effect on Gut Microbiota With Altered FODMAP Intake in Patients with Crohn's Disease: A Randomised, Controlled Cross-Over Trial of Well-Defined Diets. Clin Transl Gastroenterol (2016) 0.79

The Effect of Dietary Intervention on Irritable Bowel Syndrome: A Systematic Review. Clin Transl Gastroenterol (2015) 0.79

Clinical and diagnostic aspects of gluten related disorders. World J Clin Cases (2015) 0.79

Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation. United European Gastroenterol J (2015) 0.79

Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver (2017) 0.79

Changes in small intestinal chromogranin A-immunoreactive cell densities in patients with irritable bowel syndrome after receiving dietary guidance. Int J Mol Med (2016) 0.78

Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice. Therap Adv Gastroenterol (2016) 0.78

Activation of the umami taste receptor (T1R1/T1R3) initiates the peristaltic reflex and pellet propulsion in the distal colon. Am J Physiol Gastrointest Liver Physiol (2014) 0.78

Molecular basis of the irritable bowel syndrome. World J Gastroenterol (2014) 0.78

Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol (2016) 0.78

Patients who avoid wheat and gluten: is that health or lifestyle? Dig Dis Sci (2014) 0.78

Advances in IBS 2016: A Review of Current and Emerging Data. Gastroenterol Hepatol (N Y) (2016) 0.78

Logical hypothesis: Low FODMAP diet to prevent diverticulitis. World J Gastrointest Pharmacol Ther (2016) 0.77

Non-celiac gluten sensitivity: Time for sifting the grain. World J Gastroenterol (2015) 0.77

Risk of low bone mineral density and low body mass index in patients with non-celiac wheat-sensitivity: a prospective observation study. BMC Med (2014) 0.77

Chronic Constipation and Constipation-Predominant IBS: Separate and Distinct Disorders or a Spectrum of Disease? Gastroenterol Hepatol (N Y) (2016) 0.77

Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Res (2016) 0.77

Diet as a therapy for irritable bowel syndrome: progress at last. Gastroenterology (2013) 0.77

Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance. Exp Biol Med (Maywood) (2017) 0.76

Neuroimaging the brain-gut axis in patients with irritable bowel syndrome. World J Gastrointest Pharmacol Ther (2016) 0.76

Addressing the Role of Food in Irritable Bowel Syndrome Symptom Management. J Nurse Pract (2016) 0.76

Perceived food intolerance and irritable bowel syndrome in a population 3 years after a giardiasis-outbreak: a historical cohort study. BMC Gastroenterol (2015) 0.76

Management Strategies for Abdominal Bloating and Distension. Gastroenterol Hepatol (N Y) (2014) 0.76

Beliefs About GI Medications and Adherence to Pharmacotherapy in Functional GI Disorder Outpatients. Am J Gastroenterol (2015) 0.76

Optimal management of constipation associated with irritable bowel syndrome. Ther Clin Risk Manag (2015) 0.75

[Can a diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) reduce the symptoms of irritable bowel syndrome?]. Korean J Gastroenterol (2014) 0.75

Lactulose Breath Test Gas Production in Childhood IBS is Associated with Intestinal Transit and Bowel Movement Frequency. J Pediatr Gastroenterol Nutr (2016) 0.75

Irritable Bowel Syndrome: A gut microbiota-related disorder? Am J Physiol Gastrointest Liver Physiol (2016) 0.75

Self-reported dietary fructose intolerance in irritable bowel syndrome: Proposed diagnostic criteria. World J Gastroenterol (2015) 0.75

[Can low FODMAP diet be considered as first-line therapy in the management of irritable bowel syndrome?]. Korean J Gastroenterol (2014) 0.75

Role of dietary FODMAPs in IBS-related symptoms. Gastroenterology (2013) 0.75

Fructose Malabsorption in Systemic Sclerosis. Medicine (Baltimore) (2015) 0.75

Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. J Neurogastroenterol Motil (2017) 0.75

Good adherence to mediterranean diet can prevent gastrointestinal symptoms: A survey from Southern Italy. World J Gastrointest Pharmacol Ther (2016) 0.75

Letter: avoid FODMAPs or follow simple tips - authors' reply. Aliment Pharmacol Ther (2015) 0.75

Reply: To PMID 24076059. Gastroenterology (2014) 0.75

[Not Available]. Praxis (Bern 1994) (2014) 0.75

The mucosal immune system: master regulator of bidirectional gut-brain communications. Nat Rev Gastroenterol Hepatol (2017) 0.75

The Role of Carbohydrate Response Element Binding Protein in Intestinal and Hepatic Fructose Metabolism. Nutrients (2017) 0.75

Low FODMAP diet. Can Fam Physician (2015) 0.75

Low FODMAP Dietary Food Lists are Often Discordant. Am J Gastroenterol (2017) 0.75

Editorial: predicting response to a low FODMAP diet in children--authors' reply. Aliment Pharmacol Ther (2015) 0.75

Mechanism-Oriented Therapy of Irritable Bowel Syndrome. Adv Ther (2016) 0.75

JPEN Journal Club 10. Blinding. JPEN J Parenter Enteral Nutr (2015) 0.75

Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World J Gastrointest Pharmacol Ther (2016) 0.75

In reply. Dtsch Arztebl Int (2014) 0.75

Food, fibre, bile acids and the pelvic floor: An integrated low risk low cost approach to managing irritable bowel syndrome. World J Gastroenterol (2015) 0.75

The relation between celiac disease, nonceliac gluten sensitivity and irritable bowel syndrome. Nutr J (2015) 0.75

Response of irritable bowel syndrome with constipation patients administered a combined quebracho/conker tree/M. balsamea Willd extract. World J Gastrointest Pharmacol Ther (2016) 0.75

Irritable bowel syndrome, the microbiota and the gut-brain axis. Gut Microbes (2016) 0.75

Restriction of FODMAP in the management of bloating in irritable bowel syndrome. Singapore Med J (2016) 0.75

Controversies and Recent Developments of the Low-FODMAP Diet. Gastroenterol Hepatol (N Y) (2017) 0.75

Use of the Biphasic (13)C-Sucrose/Glucose Breath Test to Assess Sucrose Maldigestion in Adults with Functional Bowel Disorders. Biomed Res Int (2016) 0.75

Individualized Responses of Gut Microbiota to Dietary Intervention Modeled in Humanized Mice. mSystems (2016) 0.75